Relief Therapeutics Holding AG (RLFTF): If you read the 8-k by NRXP it states th...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	1475
Boards Moderated	0
Alias Born	07/10/2013

changes_iv

Re: None

Thursday, 03/10/2022 10:20:08 PM

Thursday, March 10, 2022 10:20:08 PM

If you read the 8-k by NRXP it states they will focus on commercialization of Aviptadil in the US. It seems NRXP has relinquished their rights to Israel and Canada to Relief. They also state they are pulling out of Georgia, the surrounding areas and the EU. Those are all Relief's territory. As far as I can tell with the abrupt departure of JJ as CEO Relief is calling the shots and allowing NRXP to still be a part of aviptadil in the states in exchange of certain caveats. 1 being, JJ is out as CEO and 2 is you stop all commercialization activity in Relief's territory. Now we wait to see if there has been a change to the revenue splits between the two companies. This too is speculation but it is speculation based off factual events that have transpired over the last week or so.

Wong, Y@h00 RLFTF finance conversations

https://ir.nrxpharma.com/sec-filings/all-sec-filings/content/0000950142-22-000983/0000950142-22-000983.pdf